PUBLICATIONS · 34000246
Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet Oncol
- Publication date
- 2021 Jun
- First author
- Stratigos AJ
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Nat Rev Clin Oncol. 2021 Jul;18(7):400. doi: 10.1038/s41571-021-00528-7.
- note
- Source null
- related pmid
- 34035503
- relationship
- Comment in
Authors and identifiers
- name
- Stratigos AJ
- type
- Author
- name
- Sekulic A
- type
- Author
- name
- Peris K
- type
- Author
- name
- Bechter O
- type
- Author
- name
- Prey S
- type
- Author
- name
- Kaatz M
- type
- Author
- name
- Lewis KD
- type
- Author
- name
- Basset-Seguin N
- type
- Author
- name
- Chang ALS
- type
- Author
- name
- Dalle S
- type
- Author
- name
- Orland AF
- type
- Author
- name
- Licitra L
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Stratigos AJ
- type
- Author
- name
- Sekulic A
- type
- Author
- name
- Peris K
- type
- Author
- name
- Bechter O
- type
- Author
- name
- Prey S
- type
- Author
- name
- Kaatz M
- type
- Author
- name
- Lewis KD
- type
- Author
- name
- Basset-Seguin N
- type
- Author
- name
- Chang ALS
- type
- Author
- name
- Dalle S
- type
- Author
- name
- Orland AF
- type
- Author
- name
- Licitra L
- type
- Author
- bibliography ids
- nci-bib-a9eb2a9d10f26e97ffe5c685
- book metadata
- content sha256
- d61a8837c1e579313b4365b0e2fa28112aa95586b19bd23f396cc8ec046a6af9
- document type
- citation
- dois
- 10.1016/S1470-2045(21)00126-1
- electronic publication date
- display
- 2021 May 14
- precision
- day
- year
- 2021
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:34000246
- immutable id
- pubmed:34000246@d61a8837c1e579313b4365b0e2fa28112aa95586b19bd23f396cc8ec046a6af9
- journal
- abbreviation
- Lancet Oncol
- issn electronic
- 1474-5488
- issn print
- 1470-2045
- issue
- 6
- name
- The Lancet. Oncology
- nlm unique id
- 100957246
- pages
- 848-857
- volume
- 22
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Nat Rev Clin Oncol. 2021 Jul;18(7):400. doi: 10.1038/s41571-021-00528-7.
- note
- Source null
- related pmid
- 34035503
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 34000246
- provenance
- batch id
- 79f1021053e858d13ff3
- provider
- NCBI PubMed ESummary
- record sha256
- 53bc92411ba927e214d95e236f6e00ee3214fd6a8aa6baa547577024120cd9fd
- response sha256
- 671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
- retrieved at
- 2026-09-09T23:47:59.098265+00:00
- publication date
- display
- 2021 Jun
- precision
- month
- year
- 2021
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial.
Preserved source evidence · Not medical advice
Triangle